NEW YORK (GenomeWeb News) – Bruker reported today that its revenues in the third quarter were down 4 percent year over year, falling to $419.8 million from $439 million in Q3 2013.

It missed analysts' consensus estimates on the top and bottom line, leading to a 12 percent decline in its share price to $18.35 in early Friday trade on the Nasdaq.

The drop in revenues was driven by weakness in demand for the company's NMR, semiconductor, and data storage products, President and CEO Frank Laukien said on a conference call following the earnings release.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.